AT Bancorp’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,846
Closed -$389K 278
2016
Q4
$389K Buy
4,846
+85
+2% +$6.75K 0.05% 219
2016
Q3
$380K Sell
4,761
-342
-7% -$27.6K 0.05% 211
2016
Q2
$398K Sell
5,103
-103,551
-95% -$7.38M 0.06% 185
2016
Q1
$5.97M Buy
108,654
+23,463
+28% +$1.28M 0.9% 28
2015
Q4
$5.26M Buy
85,191
+80,088
+1,569% +$5.05M 1.45% 16
2015
Q3
$322K Sell
5,103
-404
-7% -$28.8K 0.09% 155
2015
Q2
$402K Hold
5,507
0.1% 147
2015
Q1
$361K Hold
5,507
0.1% 158
2014
Q4
$358K Hold
5,507
0.11% 148
2014
Q3
$331K Sell
5,507
-19,926
-78% -$1.3M 0.1% 159
2014
Q2
$1.76M Hold
25,433
0.53% 67
2014
Q1
$1.66M Buy
25,433
+79
+0.3% +$5.14K 0.51% 69
2013
Q4
$1.57M Buy
25,354
+473
+2% +$27.4K 0.48% 64
2013
Q3
$1.33M Buy
24,881
+106
+0.4% +$5.46K 0.47% 65
2013
Q2
$1.13M Buy
+24,775
New +$1.07M 0.41% 83

Other funds holding STJ

AT Bancorp's STJ Position: Q1 2017 in Review

AT Bancorp sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,846 shares — an estimated $389K sold.

AT Bancorp first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $5.97M in Q1 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • AT Bancorp reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • AT Bancorp sold 4,846 St Jude Medical shares in Q1 2017, an estimated $389K.
  • AT Bancorp first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • AT Bancorp's St Jude Medical position peaked at $5.97M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on AT Bancorp's 13F filing for Q1 2017, filed 3 May 2017.